Advancing NGS quality control to enable measurement of actionable mutations in circulating tumor DNA

The primary objective of the FDA-led Sequencing and Quality Control Phase 2 (SEQC2) project is to develop standard analysis protocols and quality control metrics for use in DNA testing to enhance scientific research and precision medicine. This study reports a targeted next-generation sequencing (NG...

Descripción completa

Detalles Bibliográficos
Autores principales: Willey, James C., Morrison, Tom B., Austermiller, Bradley, Crawford, Erin L., Craig, Daniel J., Blomquist, Thomas M., Jones, Wendell D., Wali, Aminah, Lococo, Jennifer S., Haseley, Nathan, Richmond, Todd A., Novoradovskaya, Natalia, Kusko, Rebecca, Chen, Guangchun, Li, Quan-Zhen, Johann, Donald J., Deveson, Ira W., Mercer, Timothy R., Wu, Leihong, Xu, Joshua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017191/
https://www.ncbi.nlm.nih.gov/pubmed/35475002
http://dx.doi.org/10.1016/j.crmeth.2021.100106

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017191/
https://www.ncbi.nlm.nih.gov/pubmed/35475002
http://dx.doi.org/10.1016/j.crmeth.2021.100106

Ejemplares similares